Turner Dean - CurveBeam Chief Officer
CVB Stock | 0.16 0.02 14.29% |
Executive
Turner Dean is Chief Officer of CurveBeam AI Limited
Address | 2800 Bronze Drive, Hatfield, PA, United States, 19440 |
Phone | 267-483-8081 |
Web | https://curvebeamai.com |
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Forough Khandan | EMvision Medical Devices | N/A | |
Gary BS | Ebr Systems CDR | 59 | |
Yasmin BSc | Aroa Biosurgery | N/A | |
Kate Hunt | Nova Eye Medical | N/A | |
Gregg Stenzel | Imricor Medical Systems | N/A | |
Rod MSc | Aroa Biosurgery | N/A | |
Keith Byrne | Nova Eye Medical | N/A | |
Simon Glover | 4Dmedical | N/A | |
Naomi Lawrie | 4Dmedical | N/A | |
Aidan BE | 4Dmedical | N/A | |
BS MS | Ebr Systems CDR | 58 | |
John Sellers | Ebr Systems CDR | N/A | |
MBA BS | 4Dmedical | N/A | |
Matt Tucker | 4Dmedical | N/A | |
Mark Flynn | Nova Eye Medical | N/A | |
Don Watton | Nova Eye Medical | N/A | |
Erik Strandberg | Ebr Systems CDR | 47 | |
Neetha AlexKumar | Aroa Biosurgery | N/A | |
Michael Curtis | 4Dmedical | N/A | |
Kimberley Menzies | Nova Eye Medical | N/A | |
Greg Englehardt | Imricor Medical Systems | N/A |
Management Performance
Return On Equity | -2.87 | ||||
Return On Asset | -0.21 |
CurveBeam AI Limited Leadership Team
Elected by the shareholders, the CurveBeam's board of directors comprises two types of representatives: CurveBeam inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CurveBeam. The board's role is to monitor CurveBeam's management team and ensure that shareholders' interests are well served. CurveBeam's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CurveBeam's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ura Auckland, CFO Secretary | ||
Turner Dean, Chief Officer | ||
Pr Seeman, Medical Endocrinology | ||
Aloys Mbala, CoFounder | ||
Vinti Singh, Vice Marketing | ||
Arun Singh, CTO COO | ||
Yu BS, Chief Officer | ||
Ali Ghasemzadeh, CoFounder |
CurveBeam Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CurveBeam a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -2.87 | ||||
Return On Asset | -0.21 | ||||
Operating Margin | (3.01) % | ||||
Current Valuation | 69.9 M | ||||
Shares Outstanding | 389.8 M | ||||
Shares Owned By Insiders | 40.53 % | ||||
Shares Owned By Institutions | 29.59 % | ||||
Price To Book | 1.55 X | ||||
Price To Sales | 9.26 X | ||||
Revenue | 6.53 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CurveBeam Stock Analysis
When running CurveBeam's price analysis, check to measure CurveBeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CurveBeam is operating at the current time. Most of CurveBeam's value examination focuses on studying past and present price action to predict the probability of CurveBeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CurveBeam's price. Additionally, you may evaluate how the addition of CurveBeam to your portfolios can decrease your overall portfolio volatility.